0001209191-11-059456.txt : 20111205 0001209191-11-059456.hdr.sgml : 20111205 20111205155601 ACCESSION NUMBER: 0001209191-11-059456 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111201 FILED AS OF DATE: 20111205 DATE AS OF CHANGE: 20111205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC CENTRAL INDEX KEY: 0001008848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 SKYLINE DRIVE CITY: HAWTHORNE STATE: NY ZIP: 10532 BUSINESS PHONE: 914-347-4300 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAWRENCE DAVID CENTRAL INDEX KEY: 0001272353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50513 FILM NUMBER: 111243086 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 15 SKYLINE DRIVE CITY: HAWTHORNE STATE: NY ZIP: 10532 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-12-01 0 0001008848 ACORDA THERAPEUTICS INC ACOR 0001272353 LAWRENCE DAVID 15 SKYLINE DRIVE HAWTHORNE NY 10532 0 1 0 0 Chief Financial Officer Common Stock 2011-12-01 4 S 0 9896 22.92 D 16249 D Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $22.73 to $23.15 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. /s/ David Lawrence 2011-12-05